• Login
    Browsing Dementia by Subject 
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Dementia
    • Browsing Dementia by Subject
    •   ORKA Home
    • Conditions, Lifestyle Factors & Interventions
    • Conditions
    • Dementia
    • Browsing Dementia by Subject
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browsing Dementia by Subject "Alzheimer's Disease"

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Sort by:

    Order:

    Results:

    Now showing items 1-13 of 13

    • title
    • issue date
    • submit date
    • xmlui.ArtifactBrowser.ConfigurableBrowse.sort_by.discipline
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review 

        Murphy, Susannah E (2018-07)
        APOE-ε4 is best known as a risk factor for Alzheimer's disease (AD). Consequently, there is considerable research interest in understanding whether APOE-ε4 influences cognition in healthy adults. Despite a substantial ...
      • Thumbnail

        Care needs of people with dementia in the peri-operative environment: A systematic review 

        Jackson, Debra (2018-11)
        The care of people with dementia within the hospital setting is challenging for healthcare professionals. Hospital design and services are not optimized for people with dementia, owing to the lack of preparation of healthcare ...
      • Thumbnail

        CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice 

        Lovestone, Simon (2019-08)
        Neuroinflammation and microglial activation are significant processes in Alzheimer’s disease pathology. Recent genome-wide association studies have highlighted multiple immune-related genes in association with Alzheimer’s ...
      • Thumbnail

        Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil 

        Cipriani, Andrea (2022-02)
        The association between early improvement and subsequent change in cognition is unexamined in antidementia clinical trials. We aimed to examine the consequences of early-response to antidementia medication in Alzheimer's ...
      • Thumbnail

        Ethics of Early Intervention in Alzheimer’s Disease 

        External author(s) only (2021-03)
        Alzheimer’s disease (AD) research, treatment, and prevention focus increasingly on developing personalized interventions based on personal genetic, biological, phenotypic data, for early intervention (EI) to limit harm. ...
      • Thumbnail

        Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape. 

        External author(s) only (2020-07)
        BACKGROUND:Dementia has been described as the greatest global health challenge in the 21st century on account of longevity gains increasing its incidence, escalating health and social care pressures. These pressures highlight ...
      • Thumbnail

        Identification of Substrate-specific Allosteric Fingerprints in Matrix Metalloprotease-1 on Amyloid-beta Peptide Aggregates and Drug Screening With Single Molecule Insights 

        External author(s) only (2022-02)
        Amyloid-beta peptide (Aβ) is the primary component of water-insoluble extracellular plaques, one of the critical hallmarks of Alzheimer's disease (AD). Matrix metalloproteases (MMPs) are broad-spectrum proteases with ...
      • Thumbnail

        Linking the Mini-Mental State Examination, the Alzheimer’s Disease Assessment Scale–Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil 

        Cipriani, Andrea (2020-10)
        Background The Mini-Mental State Examination (MMSE), the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog) and the Severe Impairment Battery (SIB) are widely used rating scales to assess cognition in ...
      • Thumbnail

        Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial 

        External author(s) only (2019-11)
        IMPORTANCE There are no disease-modifying treatments for Alzheimer disease (AD), the most common cause of dementia. Minocycline is anti-inflammatory, protects against the toxic effects of β-amyloid in vitro and in animal ...
      • Thumbnail

        Neurons derived from individual early Alzheimer’s disease patients reflect clinical vulnerability 

        External author(s) only (2021-11)
        Modelling sporadic Alzheimer’s disease (sAD) with patient-derived induced pluripotent stem cells (iPSCs) is challenging yet remains an important step in understanding the disease. Here we report a novel approach of sAD ...
      • Thumbnail

        Quantification of allosteric communications in matrix metalloprotease-1 on alpha-synuclein aggregates and substratedependent virtual screening 

        External author(s) only (2021-01)
        Alpha-synuclein (aSyn) has implications in pathological protein aggregations observed in neurodegenerative disorders, including Parkinson's and Alzheimer's diseases. There are currently no approved prevention and cure ...
      • Thumbnail

        Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil 

        Cipriani, Andrea (2021-02)
        Background. The extent and profiles of heterogeneity in cognitive functioning among participants in clinical trials of antidementia medication are unknown. We aimed to quantify and identify profiles of heterogeneity of ...
      • Thumbnail

        Short-term memory advantage for brief durations in human APOE ε4 carriers 

        External author(s) only (2020-06)
        The Apolipoprotein-E (APOE) ε4 gene allele, the highest known genetic risk factor for Alzheimer’s disease, has paradoxically been well preserved in the human population. One possible explanation offered by evolutionary ...

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc
         

         

        Browse

        All of ORKACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsContributor DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsContributor Discipline

        My Account

        Login

        Researcher Profiles

        Researchers

        Oxford Health copyright © 2019
        Contact Us | Send Feedback | JSPUI
        Powered by KnowledgeArc